ABF-1 (Activated B Cell Factor-1) is a basic helix-loop-helix (bHLH) transcription factor predominantly expressed in B lymphocytes. It plays a critical regulatory role in B-cell differentiation, particularly in balancing the formation of memory B cells versus antibody-secreting plasma cells . ABF-1 functions as a transcriptional repressor, modulating immune responses by influencing cell proliferation and differentiation pathways .
ABF-1 regulates key processes in adaptive immunity:
Memory B Cell Formation: ABF-1 promotes memory B cell generation by suppressing plasma cell differentiation. Ectopic expression of ABF-1 reduces antibody-secreting cells in vitro .
Plasma Cell Suppression: ABF-1 directly represses genes required for plasma cell function (e.g., XBP-1) while upregulating memory-associated markers like FCRL4 .
Cell Proliferation Control: ABF-1 limits B-cell proliferation during immune activation, as shown by reduced BrdU incorporation in ABF-1-overexpressing cells .
Transgenic mice with inducible ABF-1 expression demonstrated:
Enhanced germinal center responses and memory B cell formation.
Autoimmunity: ABF-1’s suppression of plasma cells may mitigate excessive antibody production in autoimmune disorders .
Lymphoma: ABF-1 dysregulation is linked to Hodgkin lymphoma, where it may block terminal B-cell differentiation .
While ABF-1 antibodies are primarily used in basic research, notable examples include:
ABF1 Rabbit pAb (A22789): Targets Arabidopsis thaliana ABF1 (unrelated to the human protein), used in plant ABA signaling studies .
Human ABF-1 Detection: Custom antibodies for Western blotting and immunofluorescence in B-cell research .